A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and MIDAS scores.

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...